Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P39060 (
endostatin
)
2,284
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Angiogenesis, an essential process for tumor growth, is regulated by endothelial proliferation factors and their inhibitors such as
endostatin
. Endostatin, a carboxyl-terminal fragment of
type XVIII collagen
, inhibits endothelial proliferation, angiogenesis, and tumor growth. Ornithine decarboxylase (ODC), a molecule that is overexpressed in various cancers, is associated with promoting tumor growth and angiogenesis. We found that ODC-overexpressing human cancer cells and breast cancer specimens showed suppressed expression of
type XVIII collagen
and
endostatin
. We hypothesized that ODC overexpression may facilitate angiogenesis in tumors by suppressing
endostatin
expression. ODC-overexpressing
COS
cells, which showed suppressed
type XVIII collagen
and
endostatin
expression, were established. Conditioned media derived from these cells, containing decreased levels of
endostatin
, induced significant endothelial proliferation. ODC-overexpressing cells, when transplanted into nude mice, suppressed
type XVIII collagen
expression and promoted neovascularization in vivo. Thus, overexpression of ODC facilitates endothelial proliferation by suppressing
endostatin
expression.
...
PMID:Overexpression of ornithine decarboxylase enhances endothelial proliferation by suppressing endostatin expression. 1183 May 3
Neovastat (AE-941), a naturally occurring multifunctional
antiangiogenic agent
, has been shown to inhibit key components of the angiogenic process, including matrix metalloproteinases and vascular endothelial growth factor-mediated signaling events. In this study, we report the presence of a proapoptotic activity within this compound. Neovastat treatment of bovine aortic endothelial cells caused cell death with characteristics of apoptosis, including chromatin condensation and DNA fragmentation. Neovastat markedly induced caspase-3, caspase-8, and caspase-9 activities, at similar levels to those measured in cells treated with tumor necrosis factor-alpha. Activation of caspases by Neovastat appears to be essential for its proapoptotic effects because all apoptotic features were blocked by zVAD-fmk, a broad-spectrum caspase inhibitor. The activation of caspases was correlated with the cleavage of the nuclear substrate poly(ADP-ribose) polymerase, and by a concomitant release of cytochrome c from mitochondria to the cytoplasm. Neovastat-induced apoptosis appears to be specific to endothelial cells because treatment of other cell types such as U-87,
COS
-7, NIH-3T3, and SW1353 did not result in increased caspase-3 activity. These results demonstrate that Neovastat contains a proapoptotic factor that specifically induces the activation of caspases in endothelial cells and the resulting apoptosis of these cells.
...
PMID:The antiangiogenic agent Neovastat (AE-941) induces endothelial cell apoptosis. 1249 12
The mouse
endostatin
cDNA was cloned by the total RNA of Chinese Kunming mouse liver as template with RT-PCR. The results of sequencing showed one base pair difference. The ctg was replaced by gtg(L22545 in GenBank) at position 278 base pair, causing the encoded amino acid from reported Val to Leu in this experiment. This new
endostatin
cDNA was registered in GenBank with an accession number of AF257775. The recombinant eukaryotic expression plasmid pSecTag2-ES was then constructed and transfected into
COS
-7 cells for transient expression. The results of testing by Western blotting showed an expression fragment in supernatants of pSecTag2-ES transfected
COS
-7 cells at 48 and 72 hours of transfection. Cultured HUVECs were used to detect the biological effect of supernatants in pSecTag2-ES transfected
COS
-7 after 48 hours of transfection. 3H incorporation assay showed an obvious inhibition of endothelial cell prolifetation. The results demonstrated primary that the cloned
endostatin
cDNA had biological activity.
...
PMID:[Cloning of mouse endostatin and primary analysis on its biological activity]. 1252 Sep 59
Ultrasound (US)-mediated microbubble destruction is recognized to have considerable potential for gene delivery, whereas, there is few report of its effect on enhancing liposomal transfection. In this study, we used pIRES2-EGFP/hES containing human
endostatin
(hES) cDNA as target gene to test the hypothesis that US exposure with microbubbles could improve liposomal transfection, and to investigate the possibility of intracellular delivery of ES gene using this method. Under the controlled US exposure condition with microbubbles, the plasmid:liposome was transferred into
COS
-7 cells. The transfection rate, the expression of
endostatin
and the inhibition effect of transfection-
endostatin
on endothelial cells were assessed. The results revealed that US-mediated microbubble destruction together with liposome could significantly enhance gene transfection without obvious cell damage. By this means,
endostatin
gene could be efficiently transferred into
COS
-7 cells and expressed. The transfection-
endostatin
could inhibit endothelial proliferation and migration, which suggests that the non-viral method might be useful in anti-angiogenesis therapy in the future.
...
PMID:Expression of endostatin mediated by a novel non-viral delivery system inhibits human umbilical vein endothelial cells in vitro. 1958 74